EP Patent

EP0768883A1 — Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

Assigned to Wellstat Therapeutics Corp · Expires 1997-04-23 · 29y expired

What this patent protects

Pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine, and orotate, and uridine phosphorylase inhibitors, and their use in enhancing resistance to sepsis or systemic inflammation are disclosed.

USPTO Abstract

Pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine, and orotate, and uridine phosphorylase inhibitors, and their use in enhancing resistance to sepsis or systemic inflammation are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP0768883A1
Jurisdiction
EP
Classification
—
Expires
1997-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Wellstat Therapeutics Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.